Cite
MLA Citation
Liping Liu et al.. “Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma.” Journal of hematology & oncology, vol. 9, no. 1, 2016, pp. 1–7. http://access.bl.uk/ark:/81055/vdc_100080482711.0x000066